Ranexa (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Ranexa drug offered from Gilead Sciences, Inc.. This Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
| NON-PROPRIETARY NAME: | ranolazine |
| SUBSTANCE NAME: | RANOLAZINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-01-27 |
| END MARKETING DATE: | 0000-00-00 |
Ranexa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ranexa from Gilead Sciences, Inc. |
| LABELER NAME: | Gilead Sciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/1) |
| START MARKETING DATE: | 2006-01-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-1001_91f49ac7-d683-4c63-9b79-355c13cc28e4 |
| PRODUCT NDC: | 61958-1001 |
| APPLICATION NUMBER: | NDA021526 |
Other RANOLAZINE Pharmaceutical Manufacturers / Labelers:
